Opioid victims are not getting a "fair shake" in potential $7.4 billion settlement, a claimant in the Purdue Pharmacy ...

Here's why people alleging Purdue Pharma's opioids harmed them may not see much of the proposed $7.4 billion settlement in a bankruptcy case.

Members of the family who own OxyContin maker Purdue Pharma agreed to pay up to $7.4 ... They’ve continued to deny claims of any wrongdoing. Collectively, family members have been estimated ...

Purdue Pharma planned to exit bankruptcy last year under terms that gave the Sacklers a full release from all civil opioid claims even though they themselves were not declaring bankruptcy.

Members of the family who own OxyContin maker Purdue Pharma, and the company itself ... They’ve continued to deny claims of any wrongdoing. Collectively, family members have been estimated ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself ... They’ve continued to deny claims of any wrongdoing. Collectively, family members have been estimated ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself ... They've continued to deny claims of any wrongdoing. Collectively, family members have been estimated ...